Velosef (Cefaclor) in Pregnancy: Safety Profile & Prescribing Guidance

Velosef (cefaclor) is a second-generation cephalosporin antibiotic. It is FDA Pregnancy Category B (animal studies show no fetal risk; no adequate human studies).

Safety Summary

  • Widely used in pregnancy for UTIs, respiratory, skin/soft tissue infections.
  • No consistent pattern of congenital anomalies in surveillance data.
  • Crosses placenta but fetal levels low; no teratogenicity demonstrated.

Precautions & Contraindications

  • Allergy: Avoid if history of cephalosporin or severe penicillin allergy (≈1–2% cross-reactivity).
  • Renal impairment: Dose adjust (CrCl <30 mL/min).
  • Late pregnancy: Theoretical risk of neonatal bleeding (cephamycins inhibit platelet aggregation); cefaclor less implicated but some clinicians avoid near term.
  • Pseudomembranous colitis: C. difficile risk with any antibiotic.

Prescribing Principles

  1. Use only for confirmed/suspected bacterial infection.
  2. Choose narrowest spectrum effective agent.
  3. Shortest effective duration.
  4. Discuss risks/benefits with patient; document.

Alternatives (if allergy/intolerance): penicillins (amoxicillin), macrolides (azithromycin), fosfomycin (UTI). Always culture when feasible.

Pregnancy & Health - Related Articles